Our Mission
To secure a structured investment pathway—in partnership with federal agencies, private innovators, and the public—to fund FDA trials for CMT therapies.
Get Involved
Contact Us
Email: info@cmtacure.com
Accelerating FDA trials for Charcot-Marie-Tooth Atrophy through advocacy, awareness, and action.
To secure a structured investment pathway—in partnership with federal agencies, private innovators, and the public—to fund FDA trials for CMT therapies.
Email: info@cmtacure.com